EUROIMMUN IF Sprinter and Accessories - Indonesia BPOM Medical Device Registration
EUROIMMUN IF Sprinter and Accessories is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20203818107. The device is manufactured by G.S.G. ROBOTIX S.R.L. from Italy, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. INTI MAKMUR MEDITAMA.
This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Risk Classification
Product Class
Kelas : 2
Manufacturer
G.S.G. ROBOTIX S.R.L.Country of Origin
Italy
Authorized Representative
PT. INTI MAKMUR MEDITAMAAR Address
Gandaria 8 Office Tower Lantai 16 Unit F Jl. Sultan Iskandar Muda No. 8 RT 010 RW 006
Registration Date
Jan 14, 2025
Expiry Date
Aug 30, 2028
Product Type
Pathology Equipment and Accessories
Automated slide stainer.
Invitro Diagnostics
EUROIMMUN IIFT Mosaic: Kidney (Rat) / Stomach ( Rat )
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.
EUROIMMUN EUROStar III Plus Microscope
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.
EUROIMMUN Leptin ELISA
DIAGNOSTICS BIOCHEM CANADA INC.
EUROIMMUN 25-OH Vitamin D ELISA
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.
EUROLINE Autoimmune Liver Diseases (IgG)
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.
EUROIMMUN Anti-Rubella Virus ELISA (IgG)
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.
EUROLINE Coeliac Disease Profile (IgA)
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.
EUROLINE Systemic sclerosis (Nucleoli) profile (IgG)
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.
EUROIMMUN Anti-Aquaporin-4 IIFT
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.
EUROIMMUN ANA Screen ELISA (IgG)
EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.

